Masticatory Muscle Cancers

Mastication muscle cancer refers to malignant tumors that originate in or invade the muscles responsible for chewing (the muscles of mastication). These cancers are rare and most often present as soft-tissue sarcomas—such as rhabdomyosarcoma or leiomyosarcoma—or by direct extension of head and neck carcinomas into the masseter, temporalis, medial pterygoid, or lateral pterygoid muscles. Early detection and a clear understanding of anatomy, risk factors, and treatment options are essential for optimal outcomes Cancer Resource Hub.

---

Anatomy of the Muscles of Mastication

Structure and Location

There are four primary muscles of mastication, paired on each side of the head:

• Masseter: A thick rectangular muscle on the side of the jaw, most superficial of the group Wikipedia.

• Temporalis: A fan-shaped muscle on the side of the head, filling the temporal fossa.

• Medial Pterygoid: Located on the inner aspect of the mandible, deep under the masseter.

• Lateral Pterygoid: Situated above the medial pterygoid, responsible for opening and protruding the jaw Wikipedia.

Origin and Insertion

• Masseter:

  • Origin: Zygomatic arch (cheekbone)

  • Insertion: Lateral surface of mandibular ramus and angle Kenhub

• Temporalis:

  • Origin: Temporal fossa on the skull

  • Insertion: Coronoid process of the mandible

• Medial Pterygoid:

  • Origin: Medial surface of lateral pterygoid plate and tuberosity of the maxilla

  • Insertion: Medial surface of mandibular angle

• Lateral Pterygoid:

  • Origin: Greater wing of sphenoid and lateral pterygoid plate

  • Insertion: Neck of mandible and articular disc of the temporomandibular joint

Blood Supply

• Branches of the maxillary artery, including the masseteric artery (supplying masseter) and the deep temporal arteries (supplying temporalis) Wikipedia.

• Anastomoses with facial and transverse facial arteries ensure collateral flow.

Nerve Supply

• All four muscles are innervated by the mandibular division (V₃) of the trigeminal nerve (cranial nerve V):

  • Masseteric nerve to masseter

  • Deep temporal nerves to temporalis

  • Medial and lateral pterygoid nerves to respective pterygoids Wikipedia.

Functions

1. Elevation of the mandible (closes the jaw)

2. Protrusion of the mandible (slides jaw forward)

3. Retrusion of the mandible (draws jaw backward)

4. Lateral excursion (side-to-side chewing)

5. Stabilization of the temporomandibular joint during clenching

6. Generation of bite force for crushing and grinding food Wikipedia.

---

Types of Masticatory Muscle Cancers

1. Rhabdomyosarcoma: A malignant tumor of skeletal muscle origin; most common in children and adolescents Cancer Resource Hub.

2. Leiomyosarcoma: A cancer arising from smooth muscle cells, occasionally affecting head and neck soft tissues.

3. Fibrosarcoma: Malignant tumor of fibrous connective tissue that can invade masticatory muscles.

4. Malignant Peripheral Nerve Sheath Tumor: Originating from nerve sheaths, may involve the pterygoid muscles.

5. Direct extension of squamous cell carcinoma: Oral or oropharyngeal cancers can invade adjacent mastication muscles.

6. Metastatic lesions: Rarely, distant cancers (e.g., breast, lung) metastasize to facial muscles.

---

Causes

1. Tobacco Use:
   Smoking or chewing tobacco introduces carcinogens that damage DNA in oral and facial tissues.

2. Heavy Alcohol Consumption:
   Alcohol can act as a solvent for carcinogens and impair immune surveillance.

3. Human Papillomavirus (HPV):
   High-risk HPV strains (e.g., HPV-16) are linked to oropharyngeal cancers that can invade muscles.

4. Prior Radiation Exposure:
   Therapeutic or environmental radiation to the head/neck increases sarcoma risk in muscles.

5. Genetic Syndromes:
   Conditions like Li-Fraumeni syndrome predispose to soft tissue sarcomas.

6. Chronic Inflammation:
   Long-standing infection or inflammation in the oral cavity can promote malignant changes.

7. Immunosuppression:
   Organ transplant recipients or HIV patients have higher soft tissue cancer rates.

8. Occupational Exposures:
   Work with wood dust, nickel, or formaldehyde raises head and neck cancer risk.

9. Betel Nut Chewing:
   A traditional habit in parts of Asia strongly linked to oral and muscle-invading cancers.

10. Poor Oral Hygiene:
    Chronic periodontal disease may contribute to local carcinogenesis.

11. High-Temperature Food/Drink:
    Frequent ingestion of very hot beverages can injure mucosa and underlying muscle.

12. Diet Low in Fruits and Vegetables:
    Lack of antioxidants may reduce protection against DNA damage.

13. Age:
    Risk of soft tissue sarcomas increases slightly with advancing age.

14. Previous Benign Tumor:
    Certain benign muscle tumors (e.g., rhabdomyoma) may rarely transform malignantly.

15. Family History:
    A first-degree relative with soft tissue sarcoma modestly elevates risk.

16. Chemical Carcinogens:
    UV-cured resins, certain dyes, and welding fumes have been implicated in sarcomas.

17. Chronic Mechanical Irritation:
    Ill-fitting dentures or prostheses can irritate tissues overlying mastication muscles.

18. Epstein–Barr Virus (EBV):
    EBV is associated with nasopharyngeal carcinoma that may extend into masticatory muscles.

19. Hormonal Factors:
    Estrogen or progesterone pathways may influence soft tissue tumor growth in some cases.

20. Obesity:
    Higher body mass index is linked to increased risk of certain sarcomas.

---

Symptoms

1. Swelling or Mass:
   A painless or tender lump over the jaw or temple may be the first sign.

2. Facial Asymmetry:
   One side of the face may appear fuller due to muscle-based tumor growth.

3. Pain or Tenderness:
   Aching pain in the jaw or temple, often worse with chewing.

4. Trismus (Lockjaw):
   Difficulty opening the mouth fully due to muscle involvement or tightness.

5. Difficulty Chewing:
   Reduced bite strength or fatigue when chewing food.

6. Numbness or Tingling:
   Involvement of sensory nerves can cause altered sensation in the cheek or jaw.

7. Ulceration or Bleeding:
   Skin or mucosal ulcerations may bleed if the tumor erodes through tissues.

8. Weight Loss:
   Painful chewing and swallowing can lead to decreased intake and weight loss.

9. Voice Changes:
   Tumors extending toward the oropharynx may alter speech resonance.

10. Ear Pain (Otalgia):
    Referred pain to the ear due to shared nerve pathways.

11. Lymph Node Enlargement:
    Metastatic spread may cause firm nodes under the jaw or in the neck.

12. Headache:
    Deep muscle invasion can lead to persistent temporal headaches.

13. Jaw Weakness:
    Muscle destruction may reduce the force of jaw closure.

14. Difficulty Swallowing (Dysphagia):
    Tumor extension can interfere with normal swallowing mechanics.

15. Facial Nerve Palsy:
    Rarely, large tumors may compress nearby facial nerves causing weakness.

16. Cough or Choking:
    If the tumor intrudes into the oropharynx.

17. Halitosis (Bad Breath):
    Necrotic tumor tissue may foster foul odor.

18. Fever or Night Sweats:
    Systemic signs of advanced disease in some sarcomas.

19. Skin Induration:
    Overlying skin may feel firm or tethered to underlying tissue.

20. Rapid Tumor Growth:
    Noticeable increase in size over weeks to months.

---

Diagnostic Tests

1. Physical Examination:
   Palpation of facial muscles, assessment of range of motion.

2. Ultrasound:
   Identifies soft tissue masses and guides biopsy.

3. Magnetic Resonance Imaging (MRI):
   Gold standard for delineating tumor extent in muscles Cancer Resource Hub.

4. Computed Tomography (CT) Scan:
   Detects bone involvement and calcifications.

5. Positron Emission Tomography (PET-CT):
   Assesses metabolic activity and distant metastases.

6. Fine-Needle Aspiration Biopsy:
   Quick sampling of cells for preliminary diagnosis.

7. Core Needle Biopsy:
   Larger tissue sample for histopathology.

8. Open Surgical Biopsy:
   Excisional or incisional sampling when needle biopsy is inconclusive.

9. Histopathology:
   Microscopic analysis confirming sarcoma subtype.

10. Immunohistochemistry:
    Uses markers (e.g., desmin, myogenin) to identify muscle-origin tumors.

11. Molecular Testing:
    Detects characteristic gene fusions (e.g., PAX3-FOXO1 in alveolar RMS).

12. Complete Blood Count (CBC):
    Evaluates overall health and detects anemia or infection.

13. Liver and Kidney Function Tests:
    Baseline organ function before therapy.

14. Chest X-Ray:
    Screens for lung metastases.

15. Bone Scan:
    Detects skeletal metastases.

16. Dental Panoramic Radiograph:
    Assesses mandibular involvement.

17. Endoscopy:
    Evaluates extension into oral cavity or oropharynx.

18. Audiometry:
    If ear symptoms suggest involvement near the TMJ.

19. Neurological Examination:
    Checks for nerve deficits.

20. Dental Occlusion Assessment:
    Measures bite changes due to muscle dysfunction.

---

Non-Pharmacological Treatments

1. Surgical Resection: Complete removal of tumor with clear margins.

2. Radiation Therapy: High-energy beams targeting residual cancer cells Cancer Resource Hub.

3. Hyperfractionated Radiotherapy: Smaller, more frequent radiation doses.

4. Proton Beam Therapy: Precision radiation minimizing damage to surrounding tissues.

5. Photodynamic Therapy: Light-activated drugs to kill tumor cells.

6. Cryotherapy: Freezing of small tumors under imaging guidance.

7. Thermotherapy (Hyperthermia): Heat treatment to sensitize cells to radiation.

8. Laser Ablation: Laser energy to destroy superficial lesions.

9. Stereotactic Radiosurgery: Focused radiation in one or few sessions.

10. Nutritional Counseling: High-protein diet to support healing.

11. Swallowing Therapy: Exercises to improve dysphagia.

12. Jaw-Opening Devices: Mechanical aids to treat trismus.

13. Physical Therapy: Facial muscle exercises to maintain range of motion.

14. Speech Therapy: For voice or swallowing difficulties.

15. Occupational Therapy: Techniques to adapt daily activities.

16. Psychological Support: Counseling for anxiety or depression.

17. Pain Management Techniques: Biofeedback, relaxation training.

18. Acupuncture: Adjunct for pain relief.

19. Massage Therapy: Gentle massage to reduce muscle tension.

20. Low-Level Laser Therapy: Promotes wound healing post-surgery.

21. Transcutaneous Electrical Nerve Stimulation (TENS): Pain modulation.

22. Custom Mouthguards: Protect TMJ and reduce clenching.

23. Orthodontic Splints: Relieve pressure on masticatory muscles.

24. Bio-orthodontic Adjustments: Realign occlusion to reduce strain.

25. Smoking Cessation Programs: Remove ongoing carcinogen exposure.

26. Alcohol Counseling: Support for reducing intake.

27. Yoga and Meditation: Stress reduction to improve overall well-being.

28. Support Groups: Peer support for coping with cancer.

29. Reconstructive Therapy: Early planning for post-resection rehabilitation.

30. Telemedicine Follow-Up: Regular virtual check-ins for ongoing care.

---

Drugs

1. Cisplatin: Platinum agent that cross-links DNA in cancer cells.

2. Doxorubicin: Anthracycline antibiotic interfering with topoisomerase II.

3. Ifosfamide: Alkylating agent causing DNA crosslinks.

4. Vincristine: Vinca alkaloid that inhibits microtubule formation.

5. Actinomycin D: Binds DNA and blocks RNA synthesis.

6. Cyclophosphamide: Alkylating agent commonly used in sarcoma regimens.

7. Carboplatin: Platinum compound similar to cisplatin with different toxicity.

8. Etoposide: Topoisomerase II inhibitor.

9. Paclitaxel: Stabilizes microtubules, preventing cell division.

10. Gemcitabine: Nucleoside analog disrupting DNA synthesis.

11. Ifosfamide + Etoposide: Combined regimen for high-risk sarcomas.

12. Bevacizumab: VEGF inhibitor—experimental in soft tissue sarcomas.

13. Imatinib: Tyrosine kinase inhibitor, used in certain sarcoma subtypes.

14. Trabectedin: Marine-derived agent for advanced soft tissue sarcoma.

15. Pazopanib: Multi-tyrosine kinase inhibitor for non-adipocytic sarcomas.

16. Eribulin: Microtubule dynamics inhibitor for liposarcoma (off-label use).

17. Pegylated Liposomal Doxorubicin: Formulation to reduce cardiotoxicity.

18. Temozolomide: Oral alkylating agent used experimentally.

19. Pembrolizumab: PD-1 inhibitor immunotherapy in selected sarcoma trials.

20. Nivolumab: PD-1 inhibitor with emerging data in head and neck sarcomas.

---

Surgeries

1. Wide Local Excision: Removal of tumor plus healthy margin.

2. Marginal Mandibulectomy: Partial removal of mandibular bone to achieve clear margins.

3. Hemimandibulectomy: Removal of one side of the mandible when extensively involved.

4. Radical Resection: En bloc removal of muscle, bone, and overlying skin if needed.

5. Neck Dissection: Removal of lymph nodes when metastasis is present.

6. Microvascular Free Flap Reconstruction: Using tissue from elsewhere (e.g., radial forearm flap) to rebuild defects.

7. Temporalis Muscle Flap: Local flap for small to moderate defects.

8. Fibula Free Flap: Bony reconstruction of the mandible.

9. Zygomatic Arch Resection: If the tumor invades the arch on its way to the masseter.

10. Tracheostomy: Airway protection during extensive head and neck surgery.

---

Prevention Strategies

1. Avoid Tobacco: Eliminating smoking and chewing tobacco removes the leading risk factor.

2. Limit Alcohol: Reducing or abstaining lowers synergistic cancer risk.

3. HPV Vaccination: Protects against strains linked to oropharyngeal cancers.

4. Sun Protection: For skin cancers that can invade facial muscles.

5. Maintain Oral Hygiene: Regular brushing, flossing, and dental check-ups.

6. Healthy Diet: High in fruits, vegetables, and antioxidants.

7. Regular Physical Activity: Helps maintain immune function and healthy weight.

8. Protective Equipment at Work: Masks and ventilation when exposed to dust or chemicals.

9. Prompt Treatment of Infections: Early management of oral infections to reduce chronic inflammation.

10. Routine Head and Neck Exams: By dentists or physicians for early detection of suspicious lesions.

---

When to See a Doctor

• Persistent Swelling or Lump: Lasting more than two weeks.

• New Onset Trismus: Difficulty opening your mouth fully.

• Unexplained Facial Pain: Especially if it worsens with chewing.

• Altered Sensation: Numbness or tingling on one side of the face.

• Bleeding or Ulceration: Sores in the mouth or on the face that do not heal.

---

Frequently Asked Questions (FAQs)

1. What causes mastication muscle cancer?
   Most often, it arises from mutations in muscle cells (as in rhabdomyosarcoma) or by spread of nearby oral cancers into chewing muscles.

2. Is it curable?
   When detected early and treated aggressively with surgery, radiation, and chemotherapy, many patients achieve remission.

3. How is it diagnosed?
   Diagnosis relies on imaging (MRI/CT), biopsy, and laboratory tests to identify the tumor type.

4. What are the treatment options?
   A combination of surgical resection, radiation therapy, and chemotherapy tailored to the cancer subtype.

5. How painful is the treatment?
   Pain is managed with medications, nerve blocks, and supportive therapies; most procedures are done under anesthesia.

6. What is the recovery time after surgery?
   Recovery varies from weeks to months depending on the extent of surgery and reconstruction.

7. Will I need reconstruction?
   Large resections often require microvascular free flaps or local flaps to restore function and appearance.

8. Can mastication muscle cancer spread?
   Yes—through local invasion into bone or lymph nodes, and less commonly to the lungs and bones.

9. What is the role of physiotherapy?
   Essential for restoring jaw opening, chewing function, and preventing scar contracture.

10. Are there clinical trials available?
    Many centers offer trials of targeted therapies and immunotherapies for rare sarcomas.

11. How often are follow-up visits?
    Typically every 1–3 months in the first year, spacing out as you remain disease-free.

12. Can healthy diet impact outcomes?
    Good nutrition supports healing, tolerability of treatments, and overall immune health.

13. What are the side effects of radiation?
    Commonly includes skin irritation, dry mouth, fatigue, and risk to nearby structures.

14. Is genetic testing recommended?
    For certain sarcoma subtypes and familial cancer syndromes, testing can guide therapy and screening.

15. How do I cope with emotional stress?
    Support groups, counseling, and mind-body techniques are beneficial for mental well-being.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team Rxharun and reviewed by the Rx Editorial Board Members

Last Updated: April 24, 2025.

References